Advertisement
St. Luke's has been ranked by U.S. News & World Report as one of thenation's top 50 hospitals for a number of specialties, including neurology andneurosurgery. It is the only hospital in Houston, and only one of fourhospitals in Texas, to be named a Neuroscience Center of Excellence byNeuStrategy, Inc.
Advertisement
"The addition of the CyberKnife System to our tools will furtherstrengthen our position as a provider of innovative, comprehensive and highquality care," said Youssef G. Comair, M.D., FRCSC at St. Luke's. "When wesurveyed our physicians about what new technology was needed to serve ourcommunity, they overwhelmingly believed that the CyberKnife System was thebest option for our patient population. The CyberKnife System is truly arevolutionary device that will enable us to give patients a non-surgicalalternative for treatment of cancer or other conditions affecting the nervoussystem."
St. Luke's will use the CyberKnife System primarily to treat vascularmalformations and intracranial tumors, but it will give the hospitalflexibility to treat tumors in the spine, lung, prostate, kidney and pancreasas well. Because the CyberKnife System combines robotics and sophisticatedreal-time imaging technology, it is capable of delivering high doses ofradiation to tumors anywhere in the body with sub-millimeter accuracy. Thesecapabilities eliminate the need for invasive head and body frames, which othersystems require to immobilize the patient for tumor tracking. The robotic armalso enables the system to target tumors that are unreachable by otherradiosurgery systems or surgery. As a result, the CyberKnife System offers newhope to patients who are considered inoperable, have surgically complextumors, or are seeking an alternative to surgery.
"St. Luke's is renowned for its commitment to the highest standards ofneurological and neurosurgical patient care," said Euan S. Thomson, Ph.D.,president and CEO of Accuray. "We are pleased to be working with them to offertheir patients a non-invasive alternative to brain surgery and other cancertreatments."
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only roboticradiosurgery system designed to treat tumors anywhere in the bodynon-invasively. Using continual image guidance technology and computercontrolled robotic mobility, the CyberKnife System automatically tracks,detects and corrects for tumor and patient movement in real-time throughoutthe treatment. This enables the CyberKnife System to deliver high-doseradiation with pinpoint precision, which minimizes damage to surroundinghealthy tissue and eliminates the need for invasive head or body stabilizationframes.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is aglobal leader in the field of radiosurgery dedicated to providing an improvedquality of life and a non-surgical treatment option for those diagnosed withcancer. Accuray develops and markets the CyberKnife Robotic RadiosurgerySystem, which extends the benefits of radiosurgery to include extracranialtumors, including those in the spine, lung, prostate, liver and pancreas. Todate, the CyberKnife System has been used to treat more than 40,000 patientsworldwide and currently more than 130 systems have been installed in leadinghospitals in the Americas, Europe and Asia. For more information, please visitwww.accuray.com.
Saf
